|Bid||26.52 x 0|
|Ask||26.54 x 0|
|Day's Range||25.78 - 27.49|
|52 Week Range||25.19 - 70.98|
|Beta (3Y Monthly)||5.26|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Cannabis 2.0 era has officially started. Now, Canadians can legally access a host of cannabis-infused products like beverages, vapes, and edibles.
Despite vaping concerns, Aurora Cannabis plans to introduce vape products in December. Reports of vaping-related illnesses started in late August.
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) ranks number one on the TSX 30. However, the marquee pot stock is not a great buy today.
Aphria (APHA) reported impressive results for the first quarter of fiscal 2020 on Tuesday. The stock has gained 9.6% since its earnings.
Pineapple Express actor Seth Rogen founds cannabis brand, Houseplant, with Evan Goldberg and teams up with Canopy Growth (TSX:WEED)(NYSE:CGC).
As of Tuesday, Charlotte’s Web Holdings was trading at 18.15 Canadian dollars, which implies a fall of 37.0% since its second-quarter earnings on August 14.
Aphria (TSX:APHA)(NYSE:APHA) stock jumped nicely by about 20% this morning after reporting its second profitable earnings this morning.
Mexico is fast approaching its October 23 marijuana legalization deadline. Multiple legalization proposals before parliament are creating confusion.
Canopy Growth (TSX:WEED)(NYSE:CGC) is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.
Should marijuana investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip after losing 65% of its value? Or is the stock going to shed another 75%?